1800 244 735

Helpline (02) 9874 9777

Coming soon from the HD World Congress: Oz Buzz!

This September, your HDBuzz editors Jeff Carroll and Ed Wild will be teaming up with Emmy award-winning broadcaster Charles Sabine to bring you ‘Oz Buzz’ – the hottest science news from the World Congress on Huntington’s Disease in Melbourne, Australia – September 11-14, 2011.

The World Congress on Huntington’s Disease

The World Congress on Huntington’s Disease is the biggest regular meeting of people with Huntington’s disease, people at risk, family members, friends, carers, scientists and health professionals.

It’s a unique opportunity for the global Huntington’s disease community to come together and for people to learn from each other.

For HD-affected people, it’s a great opportunity to hear directly about the latest progress towards treatments for HD, to meet scientists who are working on HD, and to find out what’s working, what’s not and what might be around the corner. Chat to your favorite researcher and thank them – or tell them to hurry up!

For scientists and care professionals, it’s a valuable time to get to know HD family members and hear about their lives. It is so motivating, for a scientist who may spend all day looking down a microscope, to meet the people his or her work is trying to help.

The World Congress is held every two years. This year’s is in Melbourne, Australia – at the Melbourne Convention and Exhibition Centre. It’s the first time the World Congress has been held outside Europe and America.

The Congress begins on Sunday 11th September 2011 and ends on Wednesday 14th September.

Registration is open via the World Congress website at http://worldcongress-hd2011.org/. Family members get a discounted registration price of 320 Australian dollars (about 240 US dollars, 240 Euros or 210 British pounds).

HDBuzz has seen a sneak preview of the Congress timetable and we’re really excited at the quality and diversity of speakers and poster presentations.

Our advice – beg, borrow or steal to get to Melbourne in September.

Announcing … Oz Buzz!

We’re excited to announce that your HDBuzz editors-in-chief, Jeff Carroll and Ed Wild, will be presenting a nightly feature at the World Congress – which we’re calling Oz Buzz.

Oz Buzz will bring you all the hottest science news of the World Congress, with the HDBuzz ethos: the latest research news – brought to you by scientists – in plain language – for the global HD community.

We’ll be joined by our friend, Emmy award-winning broadcaster and former NBC News anchor, Charles Sabine. Charles will be hosting the Oz Buzz feature, and making sure Jeff and Ed stay on track without lapsing into jargon and science-speak.

You might be familiar with the ‘triplet repeat’ of Charles, Ed and Jeff, from their popular ‘Evening News’ presentations at the 2009 World Congress in Vancouver and the 2010 Euro-HD Meeting in Prague. You can watch videos of those ‘Evening News’ slots online.

What’s new about Oz Buzz?

With Oz Buzz, we aim to build on the success of our previous ‘Evening News’ features, while unveiling a new format that will allow us to delve a bit deeper into the most exciting science from the Congress.

Of course, not everyone can make it to Melbourne. So we want to emphasize the truly global nature of the 2011 World Congress, by using internet and social media technology to connect with the hundreds of thousands of HD-affected people around the globe.

We don’t want to give away too much just yet – but look forward to:

    n

  • Twitter science updates from the Congress in real time

  • n

  • Live interviews, in plain language with the top scientists and clinicians

  • n

  • Online interactive text and video Q & A sessions

  • n

  • Real time video feeds of Oz Buzz

  • n

  • Special guests

  • n

Watch this space

Closer to September, we’ll post instructions for how you can interact with the World Congress via Oz Buzz.

In the meantime, to catch our live science updates from Melbourne, sign up to our Twitter feed by following HDBuzzFeed.

And don’t forget to head over to http://worldcongress-hd2011.org/, where you can check out the program and register to attend.

We hope to see you in Oz!

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Scientists identify precisely how pridopidine works in models of Huntington’s disease

Published date: 12 June, 2021

Pridopidine is a drug developed to treat Huntington’s disease (HD) and now scientists have a clearer understanding of how it works in the body and brain. In a series of academic papers, researchers figured out that pridopidine is working by targeting a particular receptor protein called S1R. With this new understanding, the researchers believe pridopidine ... Read more

Huntington's disease therapeutics conference 2021 – Day 3

Published date: 29 April, 2021

We are back for the last day of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can find with the hashtag #HDTC2021. The final session of the conference will provide the latest news on more Huntington’s disease clinical programs. A new way ... Read more

Huntington's disease therapeutics conference 2021 – Day 2

Published date: 28 April, 2021

We are back with Day 2 of the virtual 2021 CHDI Therapeutics conference. This article summarises our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning session focussed on promising HD therapeutics that are in preclinical development and the afternoon session covered different ... Read more

Huntington’s disease therapeutics conference 2021 – Day 1

Published date: 28 April, 2021

The CHDI Therapeutics Conference 2021 kicked off today. This article summarizes our live Twitter updates on the exciting science being presented, which you can continue to follow with the hashtag #HDTC2021. The morning of Day 1 focused on clinical trial updates, while the afternoon explored genetic modifiers of HD and how they might be harnessed ... Read more

Huntington’s disease clinical trial round up

Published date: 26 April, 2021

It seems like the HD community has been inundated with updates from different companies and clinical trials recently. The news is far from complete doom and gloom; although there have been some real disappointments from some of the frontrunner trials, there are also positive updates from many different companies and lots of reasons for us ... Read more

Good news from uniQure: gene therapy trial on track, and promising data in animals

Published date: 15 April, 2021

Two recent press releases from uniQure provide welcome good news: the first ever HD gene therapy, known as AMT-130, has been administered via brain surgery to a small set of participants in an early safety trial. At the same time, uniQure has published findings in HD animal models that increase confidence in the drug’s ability ... Read more